Terpene Technologists Report Anti-Covid Breakthrough

CANNABIS CULTURE – Israeli-based Technologies firm Eybna says a recently discovered combination of terpenes and CBD has the potential to manage the symptoms of COVID-19, and may even prevent infection altogether. 

Nadav Eyal, CEO and co-founder of Eybna

“We used our database and advanced data-mining and formulation design methodologies to research and isolate terpenes with elevated anti-inflammatory properties and optimize their ratios.” Says Nadav Eyal CEO and co-founder of Eybna. “This enabled us to develop and manufacture a patented data-driven terpene formulation that is effective, safe, and synergetic.”

For the last 6 years, Eybna has been studying the therapeutic benefits of the cannabis plant and its phytochemicals for use in adult wellness products.  When COVID-19 first emerged, Eybna partnered with CannaSoul to analyze the potential of terpenes and cannabis phytotoxins.  Eyal states, “With the lack of safe anti-inflammatory pharmaceutical drugs, we decided to put our knowledge and formulation technology to the test – by demonstrating their efficacy versus dexamethasone, a steroid which has many unknown side effects. The results of this study exceeded our expectations.”  

Aptly named NT-VRL, this formulation consists of terpenes from sources such as eucalyptol, beta caryophyllene, and

Read More Here…

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Bud Digest

Scroll to Top